GP-1681
GP-1681 is a Beraprost sodium analogue. GP-1681 can be used in the research of influenza A H5N1 infection[1].
Product Specifications
CAS Number
1290611-29-8
UNSPSC
12352005
Target
Drug Derivative; Influenza Virus
Related Pathways
Anti-infection; Others
Applications
COVID-19-anti-virus
Field of Research
Infection
Smiles
O=C(O[Na])CCCC1=C(O[C@]2([H])[C@@]3([H])[C@@H](/C=C/[C@@H](O)C(C)CC#CC)[C@H](O)C2)C3=CC=C1
Molecular Formula
C24H29NaO5
Molecular Weight
420.47
References & Citations
[1]Mason V L. 27th International Conference of the International Society of Antiviral Research (ICAR) -Raleigh, North Carolina, USA-May 12-16, 2014. Drugs of the Future, 2014, 39 (7) .
Shipping Conditions
Room temperature
Scientific Category
Reference compound1
Clinical Information
No Development Reported
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
TRC-A433470-250MG 250 mg
3-Anilino-4-[1-(3-imidazol-1-ylpropyl)indol-3-yl]pyrrole-2,5-dione
Sign In for Pricing
View Details